天美传媒

Abstract

Lung cancer remains a leading cause of cancer-related deaths globally, with its high mortality rate emphasizing the critical need for advancements in diagnosis and treatment. This review article provides an overview of recent progress in understanding and managing lung cancer, focusing on key areas including molecular mechanisms, diagnostic advancements, and therapeutic innovations. Significant strides have been made in identifying genetic mutations such as EGFR, KRAS, ALK, and ROS1, which have paved the way for targeted therapies and personalized treatment approaches. Diagnostic techniques, including low-dose computed tomography (LDCT) and liquid biopsies have improved early detection and monitoring. Advances in treatment options, from traditional chemotherapy and radiotherapy to novel targeted therapies and immunotherapies, offer new hope for patients. The article also highlights ongoing research and emerging trends, such as personalized medicine and novel therapeutic agents, which are crucial for overcoming current challenges in lung cancer management. This comprehensive review underscores the importance of continued research to enhance early detection, optimize treatment strategies, and ultimately improve patient outcomes.